Levels and in vitro functional effects of circulating anti-hinge antibodies in melanoma patients receiving the immune checkpoint inhibitor pembrolizumab

Overview of attention for article published in PLOS ONE, September 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 2 X users

Readers on

mendeley: 6 Mendeley

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 1,497 followers.

Levels and in vitro functional effects of circulating anti-hinge antibodies in melanoma patients receiving the immune checkpoint inhibitor pembrolizumab. https://t.co/JWHIlyVo38 https://t.co/lzqwXs0Es5

Levels and in vitro functional effects of circulating anti-hinge antibodies in melanoma patients receiving the immune checkpoint inhibitor pembrolizumab https://t.co/RguY4o1Bp2

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.